Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(3)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06385457Not ApplicableActive Not Recruiting

The Effects of Mindhelper.dk: a Self-guided Digital Mental Health Promotion Service Targeting Young People

Role: collaborator

NCT06710184Phase 4Recruiting

Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction

Role: collaborator

NCT04688788Phase 3Active Not Recruiting

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Role: collaborator

NCT03751774Not ApplicableCompleted

The MAMAACT Intervention

Role: collaborator

NCT03651011Not ApplicableCompleted

Navigated Laser In Branch Retinal Vein Occlusion Study

Role: collaborator

All 5 trials loaded